01 ·Key topics of the Call
Projects should address at least two of the following:
- Development of novel therapies in a pre-clinical setting.
- Creation and validation of predictive and pharmacodynamic biomarkers.
- Replication of pre-clinical findings to enhance reliability.
- Pre-clinical proof-of-concept studies for therapy readiness.
Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.
02 ·Important Dates
- Call Launch: December 10, 2024
- Pre-proposal Submission Deadline: February 13, 2025
- Full Proposal Invitations: Early May 2025
- Funding Decisions: December 2025
03 ·Join Our Information Webinars
Learn more about the call and how to apply by attending our JTC 2025 Information Webinars:
- 17 December, 2024.
- 14 January, 2025.
The recordings of the webinars are available upon request by completing the JTC 2025 Webinars Recording Form.
Don’t miss this opportunity to contribute to groundbreaking research in rare diseases.
04 ·Downloadable documents
Call documents were updated on January 16th, 2025.
Updated items:
- Call text: addition of Ministry of Health of the Republic of Slovenia (SI MoH), Slovenia, to funding organisations participating in the call and to underrepresented countries list
- Guidelines: changes in national guidelines for FCT, CIHR, RCN, BMBF, multinational PAO funding; addition of national guidelines for SI MoH, Slovenia.
- Pre-proposal submission preview: removal of budget justification entries
- FAQ: additional Q&A
Call documents were updated on January 23th, 2025.
Updated items:
- Call text: update of Polish contact point
- Guidelines: changes in multinational PAO funding – removal of Croatia and Malta from list of eligible countries
- FAQ webinar December 17th: changes in multinational PAO funding – removal of Croatia and Malta from list of eligible countries; additional Q&A
